5-108364824-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001163315.3(FBXL17):āc.1288A>Gā(p.Ile430Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000103 in 1,460,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001163315.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL17 | NM_001163315.3 | c.1288A>G | p.Ile430Val | missense_variant | 3/9 | ENST00000542267.7 | NP_001156787.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL17 | ENST00000542267.7 | c.1288A>G | p.Ile430Val | missense_variant | 3/9 | 1 | NM_001163315.3 | ENSP00000437464.2 | ||
FBXL17 | ENST00000496714.2 | c.295A>G | p.Ile99Val | missense_variant | 2/7 | 1 | ENSP00000418111.2 | |||
FBXL17 | ENST00000518486.1 | n.560A>G | splice_region_variant, non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250852Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135562
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460896Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726742
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.1288A>G (p.I430V) alteration is located in exon 3 (coding exon 3) of the FBXL17 gene. This alteration results from a A to G substitution at nucleotide position 1288, causing the isoleucine (I) at amino acid position 430 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at